CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 74 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $16,000 | -90.2% | 30,431 | -81.0% | 0.00% | -92.9% |
| Q3 2021 | $164,000 | +5.1% | 160,380 | +88.6% | 0.01% | -6.7% |
| Q2 2021 | $156,000 | -48.2% | 85,031 | -44.3% | 0.02% | -28.6% |
| Q1 2021 | $301,000 | +56.8% | 152,726 | -0.8% | 0.02% | 0.0% |
| Q4 2020 | $192,000 | -20.0% | 153,908 | +439.1% | 0.02% | -25.0% |
| Q2 2020 | $240,000 | +147.4% | 28,550 | +60.2% | 0.03% | +211.1% |
| Q4 2019 | $97,000 | -51.3% | 17,817 | -37.8% | 0.01% | -25.0% |
| Q2 2019 | $199,000 | +165.3% | 28,660 | +123.7% | 0.01% | +200.0% |
| Q4 2018 | $75,000 | -21.9% | 12,812 | +0.3% | 0.00% | -33.3% |
| Q3 2018 | $96,000 | -3.0% | 12,779 | -34.9% | 0.01% | +50.0% |
| Q2 2018 | $99,000 | +11.2% | 19,638 | +35.2% | 0.00% | -20.0% |
| Q1 2018 | $89,000 | – | 14,523 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |